TRPV3 and Alzheimer disease: Activation of endogenous transient receptor potential vanilloid 3 (TRPV3) activity in KCs has been implicated in promoting the development of AD, but according to Yujing Wang's team, direct inhibition of TRPV3 with Scutellarein can ameliorate carvacrol‐induced proliferative and proinflammatory responses.78